Industry veteran, Tyler Martin, M.D., appointed as chief executive officer Management includes key members of the team that developed Prevnar vaccines Exclusive licensing agreement on pneumococcal vaccine composition patent in the U.S. and Japan.

 

LINCOLN, Neb., January 30, 2023 – Aeolian Biotech Corp. today announced the formation and launch of the Company to focus on the development of an improved pneumococcal conjugate vaccine, ‘iPCV22’,... read more